Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 23298  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Parkinson's disease: A review

Radhakrishnan Divya M, Goyal Vinay

Year : 2018| Volume: 66| Issue : 7 | Page no: 26-35

   This article has been cited by
 
1 Chemically induced models of Parkinson's disease
Thilaga Thirugnanam, Kirankumar Santhakumar
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2022; 252: 109213
[Pubmed]  [Google Scholar] [DOI]
2 Application of neurotoxin- and pesticide-induced animal models of Parkinsonís disease in the evaluation of new drug delivery systems
Yaquelyn Casanova, Sofia Negro, Emilia Barcia
Acta Pharmaceutica. 2022; 72(1): 35
[Pubmed]  [Google Scholar] [DOI]
3 Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinsonís Disease
Gleyce Fonseca Cabral, Ana Paula Schaan, Giovanna C. Cavalcante, Camille Sena-dos-Santos, Tatiane Piedade de Souza, Natacha M. Souza Portís, Jhully Azevedo dos Santos Pinheiro, ¬ndrea Ribeiro-dos-Santos, Amanda F. Vidal
International Journal of Molecular Sciences. 2021; 22(18): 9839
[Pubmed]  [Google Scholar] [DOI]
4 Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo, Mariarosa Anna Beatrice Melone
Pharmaceutics. 2021; 13(11): 1897
[Pubmed]  [Google Scholar] [DOI]
5 Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
Dejan Aleksic, Srdan Stefanovic, Miloö Milosavljevic, Jovana Milosavljevic, Slobodan Jankovic
Hospital Pharmacology - International Multidisciplinary Journal. 2021; 8(3): 1099
[Pubmed]  [Google Scholar] [DOI]
6 The Correlation Between Parkinsonís Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review
Niki Shrestha, Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan B Singh, Maduka C Nnadozie, Muhammad Abdal, Lubna Mohammed
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 Title of the manuscript: Mechanistic insights into chalcone butein-induced inhibition of a-synuclein fibrillation: Biophysical and insilico studies
Tinku, Harshad Paithankar, Ankita R. Rane, Ramakrishna V. Hosur, Sinjan Choudhary
Journal of Molecular Liquids. 2021; 334: 116105
[Pubmed]  [Google Scholar] [DOI]
8 Mutational Impact on ďin-Between-RingĒ (IBR) Domain of PARKIN on Protein Stability and Function
Sima Biswas, Angshuman Bagchi
Applied Biochemistry and Biotechnology. 2021; 193(6): 1603
[Pubmed]  [Google Scholar] [DOI]
9 Recent Progress in Non-motor Features of Parkinsonís Disease with a Focus on Circadian Rhythm Dysregulation
Yufei Liu, Long Niu, Xinyao Liu, Cheng Cheng, Weidong Le
Neuroscience Bulletin. 2021; 37(7): 1010
[Pubmed]  [Google Scholar] [DOI]
10 Automatic and non-invasive Parkinsonís disease diagnosis and severity rating using LSTM network
Balaji E., Brindha D., Vinodh Kumar Elumalai, Vikrama R.
Applied Soft Computing. 2021; 108: 107463
[Pubmed]  [Google Scholar] [DOI]
11 Therapeutic Regime to Ameliorate Quality of Life in Patients with Parkinsonís Disease
Nidhi Sharma, Manpreet Kaur, Anju Goyat, Priyanka Sharma, Adarsh Kumar Srivastav, B. K. Agrawal
Physical & Occupational Therapy In Geriatrics. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
12 Effects of domotics on cognitive, social and personal functioning in patients with Parkinsonís disease: A pilot study
Desiree Latella, Maria Grazia Maggio, Giuseppa Maresca, Adriana Andaloro, Smeralda Anchesi, Valentina Pajno, Rosaria De Luca, Giuseppe Di Lorenzo, Alfredo Manuli, Rocco Salvatore CalabrÚ
Assistive Technology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy
Rongbo Zhang, Jing Li, You Wu, Shunli Liang, Linsheng Xu
Genetic Testing and Molecular Biomarkers. 2021; 25(1): 20
[Pubmed]  [Google Scholar] [DOI]
14 Neuroprotective effects of oleuropein: Recent developments and contemporary research
Masood Sadiq Butt, Urwa Tariq, Iahtisham-Ul-Haq, Ambreen Naz, Muhammad Rizwan
Journal of Food Biochemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
15 The Positive Role and Mechanism of Herbal Medicine in Parkinsonís Disease
Rong Yin, Jie Xue, Yanfeng Tan, Chuantao Fang, Chunchun Hu, Qian Yang, Xinyu Mei, Dashi Qi, Silvana Hrelia
Oxidative Medicine and Cellular Longevity. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
16 Cross-talks among GBA mutations, glucocerebrosidase, and a-synuclein in GBA-associated Parkinsonís disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl, Gagandeep Kaur, Ovidiu Fratila, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Cristiana Bustea, Simona Bungau
Translational Neurodegeneration. 2021; 10(1)
[Pubmed]  [Google Scholar] [DOI]
17 The impact of clinical scales in Parkinsonís disease: a systematic review
Nikita Aggarwal, Barjinder Singh Saini, Savita Gupta
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021; 57(1)
[Pubmed]  [Google Scholar] [DOI]
18 Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinsonís Disease via Activating the JAK2/STAT3 Pathway
ZhengHu Xu, Dongfeng Yang, Xiaojing Huang, Huai Huang
Frontiers in Neuroscience. 2021; 15
[Pubmed]  [Google Scholar] [DOI]
19 Local Translation in Nervous System Pathologies
MarŪa Gamarra, Aida de la Cruz, Maite Blanco-Urrejola, Jimena Baleriola
Frontiers in Integrative Neuroscience. 2021; 15
[Pubmed]  [Google Scholar] [DOI]
20 The Histaminergic System in Neuropsychiatric Disorders
Li Cheng, Jiaying Liu, Zhong Chen
Biomolecules. 2021; 11(9): 1345
[Pubmed]  [Google Scholar] [DOI]
21 Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinsonís Disease: A Perspective on Associated Therapeutic Interventions
Tapan Behl, Gagandeep Kaur, Simona Bungau, Rishabh Jhanji, Arun Kumar, Vineet Mehta, Gokhan Zengin, Roxana Brata, Syed Shams ul Hassan, Ovidiu Fratila
International Journal of Molecular Sciences. 2020; 21(17): 6235
[Pubmed]  [Google Scholar] [DOI]
22 Neuroprotective Activity of Protocatechuic Acid (3,4-Dihydroxybenzoic Acid) to Treat Parkinsonís Disease
Jagatheesh Kaliaperumal, Satguru Dulari, Pandurangan A. , Mahendra Singh Rathore, Amit Mittal, Md. Shamshir Alam
Journal of Evolution of Medical and Dental Sciences. 2020; 9(34): 2466
[Pubmed]  [Google Scholar] [DOI]
23 Orally Administered Nanotherapeutics For Parkinsonís Disease: An Old Delivery System Yet More Acceptable
Nidhi Aggarwal, Zufika Qamar, Saleha Rehman, Sanjula Baboota, Javed Ali
Current Pharmaceutical Design. 2020; 26(19): 2280
[Pubmed]  [Google Scholar] [DOI]
24 Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinsonís Disease
Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora
Current Neuropharmacology. 2020; 19(2): 233
[Pubmed]  [Google Scholar] [DOI]
25 The potential role of metformin in the treatment of Parkinson's disease
Mengnan Lu, Huangtao Chen, Fayi Nie, Xinyi Wei, Zhiwei Tao, Jie Ma
Journal of Bio-X Research. 2020; 3(1): 27
[Pubmed]  [Google Scholar] [DOI]
26 Curcumin and neurological diseases
Raffaella Adami, Daniele Bottai
Nutritional Neuroscience. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
27 Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinsonís disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
Chen-hong Guo, Ting Cao, Long-tai Zheng, John L Waddington, Xue-chu Zhen
Acta Pharmacologica Sinica. 2020; 41(4): 499
[Pubmed]  [Google Scholar] [DOI]
28 Subcutaneous apomorphine in advanced Parkinsonís disease and its use in Indian population
Vinod Metta, Rupam Borgohain, Prashanth L Kukkle, Rukmini Mridula, Pankaj Agarwal, Asha Kishore, Vinay Goyal, Ray Chaudhuri
Annals of Movement Disorders. 2020; 3(3): 145
[Pubmed]  [Google Scholar] [DOI]
29 Natural Approaches for Neurological DisordersóThe Neuroprotective Potential of Codium tomentosum
Joana Silva, Alice Martins, Celso Alves, Susete Pinteus, Helena Gaspar, Amparo Alfonso, Rui Pedrosa
Molecules. 2020; 25(22): 5478
[Pubmed]  [Google Scholar] [DOI]
30 NŲrodejeneratif Hastalik Arastirmalarinda Drosophila melanogaster Modeli
Cem HAZIR, Gamze BORA, Hayat Erdem YURTER
Uludag ‹niversitesi Tip FakŁltesi Dergisi. 2020;
[Pubmed]  [Google Scholar] [DOI]
31 Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinsonís Disease
Siyan Zhang, Kai Tao, Jia Wang, Yunyou Duan, Bao Wang, Xi Liu
Frontiers in Cellular Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow